Synonyms: PA-824 | PA824
pretomanid is an approved drug (FDA (2019), EMA (2020))
Compound class:
Synthetic organic
Comment: Pretomanid is a nitroimidazole-based antibacterial used for the treatment of multi-drug-resistant pulmonary tuberculosis [3]. It is active against replicating and non-replicating Mycobacterium tuberculosis [1]. Pretomanid was developed by the non-profit organisation TB Alliance (www.tballiance.org.za).
|
|
Classification | |
Compound class | Synthetic organic |
Approved drug? | Yes (FDA (2019), EMA (2020)) |
WHO Essential Medicine | WHO Essential Medicines List (EML) (23rd List, 2023). Access PDF version. Click to view more information about the WHO Model Lists of Essential Medicines. |
International Nonproprietary Names | |
INN number | INN |
9871 | pretomanid |
Synonyms |
PA-824 | PA824 |
Database Links | |
Specialist databases | |
Antibiotic DB | Pretomanid (Dovprela) |
Other databases | |
BindingDB Ligand | 50363237 |
CAS Registry No. | 187235-37-6 (source: WHO INN record) |
ChEMBL Ligand | CHEMBL227875 |
DrugBank Ligand | DB05154 |
DrugCentral Ligand | 5344 |
GtoPdb PubChem SID | 434122232 |
PubChem CID | 456199 |
Search Google for chemical match using the InChIKey | ZLHZLMOSPGACSZ-NSHDSACASA-N |
Search Google for chemicals with the same backbone | ZLHZLMOSPGACSZ |
Search PubMed clinical trials | pretomanid |
Search PubMed titles | pretomanid |
Search PubMed titles/abstracts | pretomanid |
UniChem Compound Search for chemical match using the InChIKey | ZLHZLMOSPGACSZ-NSHDSACASA-N |
UniChem Connectivity Search for chemical match using the InChIKey | ZLHZLMOSPGACSZ-NSHDSACASA-N |